The next dividend from Johnson & Johnson is scheduled for Jun 4, 2024. A payout of $1.24 per share, occurring in 18 days.
Johnson & Johnson
JNJ · NYSE
Upcoming Dividends
| Amount | Payment Date | Declaration Date | Record Date |
|---|---|---|---|
| $1.24 | Jun 4, 2024 | Apr 16, 2024 | May 21, 2024 |
Recent Dividends
Johnson & Johnson has paid out $5.89 in dividends from
March 2023 to
March 2024.
During this period, there were
5 payments with an average of $1.18
paid per share.
The most recent payment occurred on
March 05, 2024
(72 days ago).
| Amount | Paid On | Declaration Date | Record Date |
|---|---|---|---|
| $1.19 | Mar 5, 2024 | Jan 2, 2024 | Feb 20, 2024 |
| $1.19 | Dec 5, 2023 | Oct 19, 2023 | Nov 21, 2023 |
| $1.19 | Sep 7, 2023 | Jul 20, 2023 | Aug 28, 2023 |
| $1.19 | Jun 6, 2023 | Apr 18, 2023 | May 23, 2023 |
| $1.13 | Mar 7, 2023 | Jan 3, 2023 | Feb 21, 2023 |
About Johnson & Johnson
Johnson & Johnson is a globally renowned, U.S.-based multinational corporation that mainly focuses on the development and manufacturing of healthcare products. Founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, the company has a proud history of more than 130 years dedicated to improving health care outcomes.
The company is headquartered in New Brunswick, New Jersey, and boasts approximately 132,000 employees worldwide as of 2021. Its personnel is deployed across around 60 countries and its products are sold in virtually every country on earth, marking Johnson & Johnson as a true global powerhouse in its sector.
As a conglomerate, Johnson & Johnson comprises 260 companies that are divided into three major segments: Pharmaceutical, Medical Devices, and Consumer Products. It plays an essential role in fields such as pharmaceuticals, diagnostic tests, orthopedic and vascular devices, as well as in providing products for baby care, skin care, oral care, wound care and etc. Familiar brands include iconic names such as Listerine, Band-Aid, Tylenol, Neutrogena, and Johnson's Baby, which are found in billions of homes globally.
Elemental to the company’s operations is its commitment to innovation and research and development. Johnson & Johnson’s significant investment in these fields ensures its standing as a leader in its sector, with a large number of patents and innovative solutions being regularly brought to market.
Notably, amidst the COVID-19 pandemic, Johnson & Johnson developed one of the vaccines granted Emergency Use Authorization in the U.S., marking its pivotal role in the global effort to combat the virus.
Johnson & Johnson has also demonstrated a commitment to corporate social responsibility, with numerous initiatives to improve global health, champion nurses, and nurture scientific innovation, reflecting in a better way the company's mission "We are committed to working with our partners to shape a more equitable and inclusive health ecosystem."
As a publicly-traded company, Johnson & Johnson is listed on the New York Stock Exchange (NYSE) under the ticker symbol 'JNJ'. Its consistent performance and reliable dividends have made it a popular choice amongst investors.
Through various investments and robust product portfolios, Johnson & Johnson continues to provide comprehensive healthcare solutions that redefine markets and improve quality of life for people around the globe.